AI Analysis
AI-generated analysis. Always verify with the original filing.
Clearmind Medicine Inc. filed a patent application in India covering next-generation psychedelic-based compounds for treating mental health disorders and addiction, expanding its global intellectual property portfolio.
Key Takeaways
1Clearmind Medicine filed a patent application in India for next-generation psychedelic-based compounds.
2The compounds are intended for the treatment of mental health disorders and addiction.
3The patent application builds upon the company's exclusive worldwide licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem.
4The company's intellectual property portfolio currently consists of nineteen patent families, including 31 granted patents.
5The company intends to seek additional patents for its compounds whenever warranted.